Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal administration, 2 mL syring...
FDA Recall #D-0064-2024 — Class II — October 2, 2023
Product Description
Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal administration, 2 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
Reason for Recall
Lack of Assurance of Sterility
Recalling Firm
Pine Pharmaceuticals, LLC — Tonawanda, NY
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
860 syringes
Distribution
Nationwide within the United States
Code Information
Lot #: 67808, Exp. Date 10/23/2023
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated